ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO1101

Effects of Hospitalization Before Hemodialysis on Mortality in Patients on Dialysis

Session Information

  • Geriatric Nephrology
    November 08, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Geriatric Nephrology

  • 1300 Geriatric Nephrology

Authors

  • Lee, Hyunwoo, Chuncheon Sacred Heart Hospital, Chuncheon-si, Gangwon-do, Korea (the Republic of)
  • Kim, Hyunsuk, Chuncheon Sacred Heart Hospital, Chuncheon-si, Gangwon-do, Korea (the Republic of)
Background

Hospitalization leads to increased frailty in the elderly, which can result in higher rates of subsequent hospitalization and mortality. This study investigated whether a history of hospitalization before initiating dialysis affected mortality rates in dialysis patients.

Methods

We studied 2,765 dialysis patients to assess whether prior hospitalization raised mortality risk, analyzing demographics, comorbidities, labs, and medications using survival analysis to calculate hazard ratios.

Results

8.0% (n=222) had been hospitalized for 1 month or longer within the year before starting dialysis. The hospitalized group was older, and many patients in this group began dialysis using a catheter. This group also had a higher prevalence of conditions such as cerebrovascular accidents (CVA), hypertension, dementia, heart failure, and atrial fibrillation. Laboratory findings revealed higher platelet counts and blood urea nitrogen (BUN) levels, but lower levels of intact parathyroid hormone, creatinine, albumin, alkaline phosphatase, and cholesterol. Additionally, this group used fewer medications, including renin-angiotensin-aldosterone system blockers, calcium channel blockers, and antiplatelet agents. Controlling for factors such as age, sex, dialysis access, comorbidities (e.g., dementia, malignancy, ischemic heart disease, CVA, heart failure, atrial fibrillation, liver cirrhosis, fractures), ejection fraction, and laboratory markers (e.g., lymphocytes, platelets, BUN, creatinine, albumin, phosphorus, total cholesterol), the HR for mortality in the group with a history of hospitalization was 1.686 (95% CI, 1.162-2.447).

Conclusion

Patients hospitalized for more than 1 month before starting dialysis had higher overall mortality rates. These findings highlight the need for comprehensive care and targeted interventions for this high-risk population.

Funding

  • Government Support – Non-U.S.

Digital Object Identifier (DOI)